BKG VET PHARMA ApS: Financial statements 2018
CVR: 34044341
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
BKG VET PHARMA ApS (CVR 34044341) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -36,050 and a net result of DKK -94,791 compared with DKK -329,327 the year before. Equity in the 2018 report amounted to DKK 225,768. The solvency ratio was 90.6%.
- Gross Profit
- DKK -36,050
- Profit/Loss
- DKK -94,791
- Equity
- DKK 225,768
- Total Assets
- DKK 249,071
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -36 t. | -95 t. | 226 t. | - |
| 2017 | - | -151 t. | -329 t. | 521 t. | - |
| 2016 | - | -94 t. | -6.1 mio. | 850 t. | - |
| 2015 | - | -125 t. | -629 t. | 7 mio. | - |
| 2014 | - | -120 t. | -42 t. | 7.6 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
BKG VET PHARMA ApS has published its annual report for 2017. Gross profit came to DKK -150,876, and the net result was DKK -329,327.
About BKG VET PHARMA ApS
BKG VET PHARMA ApS was a Danish company of the type Anpartsselskab based in Klampenborg, founded in 2011. The company has been dissolved on 31 March 2020. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company has 0 employees (2017). In 2018, the company reported a gross profit of DKK -36,050 and a net result of DKK -94,791 compared with DKK -329,327 the year before. Equity in the 2018 report amounted to DKK 225,768.